Page last updated: 2024-11-05

hexafluoroacetone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hexafluoroacetone: structure; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hexafluoroacetone : A ketone that is acetone in which all the methyl hydrogens are replaced by fluoro groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12695
CHEBI ID39429
SCHEMBL ID344
MeSH IDM0068091

Synonyms (51)

Synonym
unii-aku9463n1y
aku9463n1y ,
1,1,3,3,3-hexafluoro-2-propanone
684-16-2
nci-c56440
2-propanone,1,1,3,3,3-hexafluoro-
acetone, hexafluoro-
6fk ,
hexafluoroacetone
perfluoro-2-propanone
nsc202438
perfluoroacetone
wln: fxffvxfff
nsc-202438
gc 7887
2-propanone, 1,1,1,3,3,3-hexafluoro-
hsdb 2896
einecs 211-676-3
un2420
nsc 202438
1,1,1,3,3,3-hexafluoroacetone
CHEBI:39429
(cf3)2co
hexafluoropropanone
1,1,1,3,3,3-hexafluoro-2-propanone
hexafluoroacetone, 97%
hexafluoroacetone [un2420] [poison gas]
1,1,1,3,3,3-hexafluoropropan-2-one
H0425
hexafluoro-2-propanone
A836139
1,1,1,3,3,3-hexakis(fluoranyl)propan-2-one
AKOS007930603
1,1,1,3,3,3-hexafluoro-propan-2-one
1,1,1,3,3,3-hexafluoro-2-propanone [hsdb]
hexafluoroacetone [mi]
SCHEMBL344
hexafluor-oacetone
hexafluoro acetone
trifluoromethyl ketone
cf3c(o)cf3
cf3cocf3
DTXSID9043778
un 2420
2-propanone, hexafluoro-
1,1,1,3,3,3-hexafluoroacetone #
2-propanone,1,1,1,3,3,3-hexafluoro-,hydrate(2:3)
hexafluoroacetone, anhydrous
10057-27-9
mfcd00000422
Q416322

Research Excerpts

Dosage Studied

Rats dosed dermally with 39 or 130 mg/kg/day hexafluoroacetone sesquihydrate (HFA) for 14 days developed moderate or severe testicular atrophy, respectively. rats dosed with 13 mg/ kg/day HFA for 14 Days did not. Steroidogenesis was investigated in Leydig cell-enriched fractions isolated from the testes of rats.

ExcerptRelevanceReference
"Steroidogenesis was investigated in Leydig cell-enriched fractions isolated from the testes of rats dosed dermally with 130 mg/kg/day hexafluoroacetone (HFA) for 14 days and from pair-fed control rats."( Effects of hexafluoroacetone on Leydig cell steroidogenesis and spermatogenesis in the rat.
Gillies, PJ; Lee, KP, 1985
)
0.86
"Testicular atrophy was induced in rats by dermal application of hexafluoroacetone (HFA) at 39 or 130 mg/kg/day for 14 days, but not at a dosage of 13 mg/kg/day."( Ultrastructural alterations in hexafluoroacetone-induced testicular atrophy in the rat.
Gillies, PJ; Lee, KP, 1984
)
0.79
"Rats dosed dermally with 39 or 130 mg/kg/day hexafluoroacetone sesquihydrate (HFA) for 14 days developed moderate or severe testicular atrophy, respectively; rats dosed with 13 mg/kg/day HFA for 14 days did not."( Effects of hexafluoroacetone on testicular morphology and lipid metabolism in the rat.
Gillies, PJ; Lee, KP, 1983
)
0.92
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
NMR chemical shift reference compoundAny compound that produces a peak used to reference an NMR spectrum during data pre-processing.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
perfluorinated compoundAn organofluorine compound containing only C-F bonds (no C-H bonds) and C-C bonds but also other heteroatoms (particularly other halogens, oxygen, and sulfur). Their properties represent a blend of fluorocarbons (containing only C-F and C-C bonds) and the parent functionalised organic species.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (11.11)18.7374
1990's10 (27.78)18.2507
2000's13 (36.11)29.6817
2010's7 (19.44)24.3611
2020's2 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.44 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index50.33 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]